# Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques

> **NCT05088161** · — · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 20 (estimated)

## Conditions studied

- Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05088161
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-13
- **Primary completion:** 2021-11-12
- **Final completion:** 2022-03-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05088161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05088161, "Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05088161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*